FLOWERY BRANCH, Ga – After the continued issues with communication, the Atlanta Falcons will be moving offensive coordinator Zac Robinson down from the press box to the field moving forward. Head ...

It seems like the Cotswolds in England is the new Montecito; all the celebrities have to have a piece of property there. While we know there’s an influx of celebrities moving out of the US, and most ...

This takes the president’s “big, beautiful bill” a step further. It also makes changes to bolster Social Security’s finances -- but this could be the main obstacle. One Senator believes there's a way ...

President Donald Trump signed a memorandum Tuesday directing the Food and Drug Administration (FDA) to crack down on deceptive pharmaceutical ads on television and social media. The FDA will ...

The Buffalo Bills have a third-down problem. After holding the New York Jets without a conversion on third down a week ago, Buffalo followed that up by putting forth one of the worst efforts on third ...

Soft saving is a newer money mindset — especially popular among Gen Z — that's basically a middle path between living fully now and socking everything away for retirement. It acknowledges that life is ...

"His needs are met 100% of the time, as well as our two young daughters'. So I'm not gonna take a vote on that," Emma said Jen Juneau is a News and Movies Staff Writer at PEOPLE. She started at the ...

Downton Abbey producer hints grand finale film may not spell end for franchise - Russia Reacts as Trump Weighs Tomahawk Missiles for Ukraine Dolly Parton postpones concerts after doctor said she must ...

In 2025, the rising unemployment rate among Americans under 25, specifically recent graduates, has become a significant economic concern. This problem seems to be uniquely American, stemming from a ...

PAWTUCKET, R.I. — Hasbro’s relocation from Pawtucket to Boston is a symbolic and economic blow to Rhode Island, stripping the state of one of its few corporate headquarters and raising questions about ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the booming market for weight-loss medicines. The drug, known as CT-388, ...